Medication Monitor

Generic Name (Trade Name—Company)
June 20, 2011


(Oxecta—Pfizer, Acura)
Formulation has abuse-deterrent technology


Management of acute and chronic moderate to severe pain where the use of an opioid analgesic is appropriate     

Pfizer and Acura announced the approval of Oxecta, an immediate-release formulation of oxycodone tablets with specialized technology to decrease tampering associated with opioid abuse and misuse. The AVERSION technology comprises a unique composition of commonly used pharmaceutical ingredients.